glp-1 news today oct 2 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care GLP-1 RA prescription trends: January

Distribution : Distribute solution evenly across targeted areas

Effects of GLP-1 receptor agonists on incident gynecologic cancer outcomes in endometriosis patients compared to metformin: a real-world cohort

They also highlight a recurring pattern in peptide drug development: early safety signals, particularly those observed at supraphysiologic exposure levels or in non-human models, have frequently led to premature abandonment of otherwise biologically compelling targets

Enlicitide attacks that friction directly

Nearly two thirds of patients discontinue treatment before reaching the 12-week mark needed for meaningful weight loss

That's a meaningfully different claim, and it's the one you should hold the product to - not the pharmaceutical comparison the marketing sometimes leans into